NIOX Group Plc (CSSPF)
USD 0.65
(-13.33%)
USD 0.65
(-13.33%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 500 Thousand USD | 25.0% |
| 2022 | 400 Thousand USD | -55.56% |
| 2021 | 900 Thousand USD | 12.5% |
| 2020 | 800 Thousand USD | -99.45% |
| 2019 | 145.59 Million USD | 0.0% |
| 2018 | - GBP | 0.0% |
| 2017 | - GBP | 0.0% |
| 2016 | - GBP | 0.0% |
| 2015 | - GBP | 0.0% |
| 2014 | - GBP | 0.0% |
| 2013 | - GBP | 0.0% |
| 2012 | - GBP | 0.0% |
| 2011 | - GBP | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2023 FY | 500 Thousand USD | 25.0% |
| 2023 Q4 | 500 Thousand USD | -18.03% |
| 2023 Q3 | 610 Thousand GBP | -23.75% |
| 2023 Q2 | 800 Thousand USD | -18.94% |
| 2023 Q1 | 986.93 Thousand GBP | 146.73% |
| 2022 Q3 | 446.68 Thousand GBP | -50.37% |
| 2022 Q4 | 400 Thousand USD | -10.45% |
| 2022 FY | 400 Thousand USD | -55.56% |
| 2022 Q1 | 1.18 Million GBP | 31.36% |
| 2022 Q2 | 900 Thousand GBP | -23.87% |
| 2021 Q3 | 1.21 Million GBP | 10.25% |
| 2021 Q1 | 1.51 Million GBP | 89.54% |
| 2021 Q2 | 1.1 Million GBP | -27.46% |
| 2021 Q4 | 900 Thousand GBP | -25.79% |
| 2021 FY | 900 Thousand USD | 12.5% |
| 2020 Q2 | 1.3 Million GBP | -19.57% |
| 2020 FY | 800 Thousand USD | -99.45% |
| 2020 Q4 | 800 Thousand GBP | -22.5% |
| 2020 Q3 | 1.03 Million GBP | -20.6% |
| 2020 Q1 | 1.61 Million GBP | -98.89% |
| 2019 Q3 | 136.97 Million GBP | 446.33% |
| 2019 Q4 | 145.59 Million GBP | 6.29% |
| 2019 Q2 | 25.07 Million GBP | -10.46% |
| 2019 Q1 | 28 Million GBP | 0.0% |
| 2019 FY | 145.59 Million USD | 0.0% |
| 2018 Q1 | - GBP | 0.0% |
| 2018 FY | - GBP | 0.0% |
| 2018 Q4 | - GBP | 0.0% |
| 2018 Q3 | - GBP | 0.0% |
| 2018 Q2 | - GBP | 0.0% |
| 2017 Q2 | - GBP | 0.0% |
| 2017 Q1 | - GBP | 0.0% |
| 2017 FY | - GBP | 0.0% |
| 2017 Q4 | - GBP | 0.0% |
| 2017 Q3 | - GBP | 0.0% |
| 2016 Q4 | - GBP | 0.0% |
| 2016 Q1 | - GBP | 0.0% |
| 2016 FY | - GBP | 0.0% |
| 2016 Q3 | - GBP | 0.0% |
| 2016 Q2 | - GBP | 0.0% |
| 2015 Q1 | - GBP | 0.0% |
| 2015 FY | - GBP | 0.0% |
| 2015 Q4 | - GBP | 0.0% |
| 2015 Q3 | - GBP | 0.0% |
| 2015 Q2 | - GBP | 0.0% |
| 2014 Q4 | - GBP | 0.0% |
| 2014 Q1 | - GBP | 0.0% |
| 2014 Q2 | - GBP | 0.0% |
| 2014 Q3 | - GBP | 0.0% |
| 2014 FY | - GBP | 0.0% |
| 2013 Q3 | - GBP | 0.0% |
| 2013 Q4 | - GBP | 0.0% |
| 2013 Q1 | - GBP | 0.0% |
| 2013 FY | - GBP | 0.0% |
| 2012 FY | - GBP | 0.0% |
| 2011 FY | - GBP | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Avitar, Inc. | 3.89 Million USD | 87.168% |
| BioElectronics Corporation | 12.52 Million USD | 96.009% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 161 Thousand USD | -210.559% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -330.834% |
| Polarean Imaging plc | 74.84 Thousand USD | -568.038% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -11.239% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | 99.84% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | 97.349% |
| Össur hf. | 311.8 Million USD | 99.84% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | 19.094% |
| Escalon Medical Corp. | 279.4 Thousand USD | -78.952% |
| Aurora Spine Corporation | 1.59 Million USD | 68.589% |
| BrainsWay Ltd. | 239 Thousand USD | -109.205% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 16.7 Million USD | 97.007% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 99.939% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -129.768% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -1044.793% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | 15.254% |
| Nanomix Corporation | 10.11 Million USD | 95.055% |
| Theraclion SA | 1.95 Million EUR | 74.369% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | -64.15% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -233.333% |
| Lombard Medical, Inc. | 28.02 Million USD | 98.216% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | 99.44% |
| Vycor Medical, Inc. | 243.28 Thousand USD | -105.519% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -251.299% |
| SANUWAVE Health, Inc. | 492 Thousand USD | -1.626% |
| VMS Rehab Systems, Inc. | 106.45 USD | -469604.086% |
| Guided Therapeutics, Inc. | 511 Thousand USD | 2.153% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | 6.064% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | 37.811% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | -55.086% |
| Urologix, Inc. | 4.58 Million USD | 89.097% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | -16.216% |
| Nexeon MedSystems Inc. | 2.78 Million USD | 82.055% |
| SS Innovations International, Inc. | 1.91 Million USD | 73.828% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 99.977% |
| Fuse Medical, Inc. | 200 Thousand USD | -150.0% |
| Broncus Holding Corporation | 1.22 Million USD | 59.15% |
| Brain Scientific Inc. | 7378.00 USD | -6676.904% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -208.901% |
| Health Logic Interactive Inc. | - USD | -Infinity% |